Notes from the Field: First Reports of Locally Transmitted Seoul Hantavirus Infection — District of Columbia, May 2018–December 2018
Weekly / March 4, 2022 / 71(9);359–360
Nivedita Ravi-Caldwell, DVM1; Preetha Iyengar, MD1; John Davies-Cole, PhD1 (View author affiliations)View suggested citation
Views equals page views plus PDF downloads
In May 2018, patient A, a previously healthy man aged 30 years, was evaluated at a District of Columbia (DC) health care facility for a 4-day history of chills, diarrhea, fever (103°F [39.5°C]), headache, sore throat, and vomiting. Despite symptomatic treatment with antipyretics, he subsequently experienced hemoconcentration (hematocrit = 60.4% [normal = 38.8%–50%]), thrombocytopenia (<10,000 platelets/μL [normal = 150,000–450,000]), and acute kidney injury (blood urea nitrogen [BUN] = 95 mg/dL [normal = 9–20] and creatinine = 4.95 mg/dL [normal = 0.66–1.50]) over several days (1). Approximately 1 week later, he experienced signs consistent with hemophagocytic lymphohistiocytosis, a potentially fatal systemic inflammatory syndrome, including elevated ferritin, triglycerides, and interleukin-2 levels, and hemophagocytosis cells on bone marrow biopsy (2). Patient A was a maintenance worker with frequent rodent sightings at his workplace. Serology results were positive for hantavirus immunoglobulin (Ig) M and IgG. Additional tests sent to CDC returned with hantavirus IgG and IgM titers >1:6,400, confirming recent infection with Seoul hantavirus (SEOV). Virus isolation was unsuccessful (1). Comprehensive testing for other infectious etiologies returned negative results. The patient responded to supportive treatment and was eventually discharged.
Five months later, in November 2018, patient B, a man aged 37 years with history of chronic kidney disease, was evaluated in a DC emergency department with a 3-day history of chills, fever (104°F [40.1°C]), headache, myalgia, and productive cough, followed later by diarrhea, nausea, and vomiting. On further evaluation, he had elevated hepatic transaminases (aspartate aminotransferase = 164 units/L [normal = 3–34], alanine aminotransferase = 78 units/L [normal = 15–41]), thrombocytopenia (43,000/μL), and acute kidney injury (BUN = 36 mg/dL and creatinine = 7.6 mg/dL) during his admission. The patient worked as a dishwasher and plumber’s assistant, had no recent history of travel outside the United States, and did not own any pets. He was unaware of exposure to rodents at work, at home, or during his commute. Serology sent to rule out hemorrhagic fever-renal syndrome returned with IgG and IgM titers of >1:6,400, confirming recent infection with SEOV. Comprehensive testing for other infectious etiologies returned negative results. The patient responded to supportive treatment and was eventually discharged.
SEOV is a type of hantavirus previously associated with hemorrhagic fever-renal syndrome.* Patient A is believed to have had the first case of hemophagocytic lymphohistiocytosis related to hantavirus infection reported in the United States and the second worldwide (1,3). Past studies have documented that Norway rats serve as the reservoir species for SEOV in the United States (1,4), and previous cases of hantavirus infection have been linked to wild or pet rodents (4,5). Humans can become infected with SEOV through aerosol exposure to virus shed in rodent feces, saliva, or urine. Rodent overpopulation in DC is well documented by increased complaints via the Citywide Call Center to the Rodent Control Program, and the DC Department of Health has amplified efforts to address this public health threat.† Although extremely rare, the two SEOV cases presented in this report highlight the importance of physicians including hantavirus infection in their differential diagnoses in patients with compatible symptoms and history of animal exposure or travel and underscore the importance of reporting notifiable infectious disease cases to health departments for investigation and response. These cases also serve as a reminder to the public to minimize risk for infection by following recommended hygiene practices.§
Aaron Kofman, Viral Special Pathogens Branch, CDC; Agueda Maradiaga, District of Columbia Department of Health; Andrew Hennenfent, Iowa Department of Public Health.
Corresponding author: Nivedita Ravi-Caldwell, firstname.lastname@example.org.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Shastri B, Kofman A, Hennenfent A, et al. Domestically acquired Seoul virus causing hemophagocytic lymphohistiocytosis—Washington, DC, 2018. Open Forum Infect Dis 2019;6:ofz404. https://doi.org/10.1093/ofid/ofz404external icon PMID:31660366external icon
- Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007;7:814–22. https://doi.org/10.1016/S1473-3099(07)70290-6external icon PMID:18045564external icon
- Lee J-J, Chung I-J, Shin D-H, et al. Hemorrhagic fever with renal syndrome presenting with hemophagocytic lymphohistiocytosis. Emerg Infect Dis 2002;8:209–10. https://doi.org/10.3201/eid0802.010299external icon PMID:11897077external icon
- Easterbrook JD, Kaplan JB, Vanasco NB, et al. A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA. Epidemiol Infect 2007;135:1192–9. https://doi.org/10.1017/S0950268806007746external icon PMID:17224086external icon
- Knust B, Brown S, de St Maurice A, et al. Multistate Seoul Virus Outbreak Investigation Team. Seoul virus infection and spread in United States home-based ratteries: rat and human testing results from a multistate outbreak investigation. J Infect Dis 2020;222:1311–9. https://doi.org/10.1093/infdis/jiaa307external icon PMID:32484879external icon
Suggested citation for this article: Ravi-Caldwell N, Iyengar P, Davies-Cole J. Notes from the Field: First Reports of Locally Transmitted Seoul Hantavirus Infection — District of Columbia, May 2018–December 2018. MMWR Morb Mortal Wkly Rep 2022;71:359–360. DOI: http://dx.doi.org/10.15585/mmwr.mm7109a3external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to email@example.com.